WallStreetZenWallStreetZen

NASDAQ: ALGN
Align Technology Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Align Technology earnings were $437.6M for the trailing 12 months ending Jun 30, 2025, with 0.7% growth year over year. The latest ALGN earnings report on Jun 30, 2025 announced Q2 2025 earnings of $124.6M, up 33.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ALGN reported annual earnings of $421.4M, with -5.3% growth.

ALGN past earnings growth

How has ALGN's earnings growth performed historically?

Company
0.68%
Industry
72.95%
Market
39.96%
ALGN's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
ALGN's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
ALGN's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

ALGN earnings history

Current Revenue
$4.0B
Current Earnings
$437.6M
Current Profit Margin
11%
ALGN's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

ALGN Return on Equity

Current Company
11.3%
Current Industry
15.2%
Current Market
30.7%
ALGN's Return on Equity (11.3%)... subscribe to Premium to read more.
High Return on Equity Performance

ALGN undefined

Current Company
7%
Current Industry
8.9%
ALGN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when ALGN announces earnings.

ALGN undefined

Current Company
14.7%
Current Industry
10.6%
ALGN's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ALGN vs Medical Device Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ALGN$815.17M$437.61M-22.78%$5.94
PEN$192.34M$147.70M+66.34%$3.82
BIO-$793.53M-$675.90MN/A-$24.21
GMED$643.01M$356.65M+23.92%$2.63
MASI-$472.60M-$569.40MN/A-$10.64
View Top Medical Device Stocks

Align Technology Earnings Reports & History FAQ

What were Align Technology's earnings last quarter?

On ALGN's earnings call on Invalid Date, Align Technology (NASDAQ: ALGN) reported Q2 2025 earnings per share (EPS) of $1.72, up 34.38% year over year. Total ALGN earnings for the quarter were $124.61 million. In the same quarter last year, Align Technology's earnings per share (EPS) was $1.28.

If you're new to stock investing, here's how to buy Align Technology stock.

Is Align Technology profitable or losing money?

As of the last Align Technology earnings report, Align Technology is currently profitable. Align Technology's net profit (also called net income) for the twelve months ending Jun 30, 2025 was $437.61 million, a 2.11% decrease year over year.

What was ALGN's earnings growth in the past year?

As of Align Technology's earnings date in Invalid Date, Align Technology's earnings has grown 0.68% year over year. This is 72.27 percentage points lower than the US Medical Devices industry earnings growth rate of 72.95%. ALGN earnings in the past year totalled $437.61 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.